TXB3 Stock Overview
Sopheon plc designs, develops, and markets software products with associated implementation and consultancy services in North America and Europe. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Sopheon plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£10.60 |
52 Week High | UK£11.00 |
52 Week Low | UK£5.35 |
Beta | 0.44 |
11 Month Change | -2.75% |
3 Month Change | 6.53% |
1 Year Change | 53.62% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 76.67% |
Recent News & Updates
Recent updates
Shareholder Returns
TXB3 | DE Software | DE Market | |
---|---|---|---|
7D | -3.6% | 1.4% | -1.3% |
1Y | 53.6% | 53.5% | 7.4% |
Price Volatility
TXB3 volatility | |
---|---|
TXB3 Average Weekly Movement | 2.0% |
Software Industry Average Movement | 5.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: TXB3 has not had significant price volatility in the past 3 months.
Volatility Over Time: TXB3's weekly volatility has decreased from 13% to 2% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 174 | Greg Coticchia | www.sopheon.com |
Sopheon plc designs, develops, and markets software products with associated implementation and consultancy services in North America and Europe. Its software solutions include Accolade, an enterprise management solution that identify, evaluate, and execute against the right strategic priorities for its portfolio; Acclaim Ideas, an idea management solution; Acclaim Products, which allows product people to track product health, prioritize trade-offs, inform stakeholders, and make decisions; and Acclaim Projects, a project management solution. The company was formerly known as PolyDoc and changed its name to Sopheon plc in 1999.
Sopheon plc Fundamentals Summary
TXB3 fundamental statistics | |
---|---|
Market cap | €124.50m |
Earnings (TTM) | -€49.08k |
Revenue (TTM) | €35.30m |
3.5x
P/S Ratio-2,536x
P/E RatioIs TXB3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TXB3 income statement (TTM) | |
---|---|
Revenue | US$38.12m |
Cost of Revenue | US$9.15m |
Gross Profit | US$28.97m |
Other Expenses | US$29.03m |
Earnings | -US$53.00k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0049 |
Gross Margin | 76.01% |
Net Profit Margin | -0.14% |
Debt/Equity Ratio | 0% |
How did TXB3 perform over the long term?
See historical performance and comparison